Hematologist/Medical Oncologist

Lee Schwartzberg, MD, FACP

Specialty Area
Medical Oncology
Locations
East Campus
7945 Wolf River Boulevard
Germantown TN 38138 901.683.0055
Lee S. Schwartzberg, MD, FACP, is the Executive Director of West Cancer Center and founding member of  West Clinic. His major research interests are new therapeutic approaches to breast cancer, targeted therapy and supportive care. He has published more than 150 research papers during his oncology career. Dr. Schwartzberg is board certified in internal medicine, hematology, and medical oncology. He maintains a private practice in medical oncology focusing on breast cancer.   The best cancer treatment programs in the world are the programs that can treat all forms of cancer in one place. That is why Dr. Schwartzberg is excited about the new partnership of the West Cancer Center. With everything under one roof, research, doctors and technology can stay close to a patient’s bedside. Patients have always had an edge over cancer with Dr. Schwartzberg on their team. The West Cancer Center gives them the added advantage of home.  

Undergraduate:

 

Medical School:

Residency:

 

Fellowship:

Dr. Schwartzberg’s recent awards include: The ASCO Cancer Foundation Clinical Trials Participation Award The 2004 Jefferson Award for Community Service America’s Top Doctors, Oncology, 2007- present American College of Physicians Tennessee Chapter Volunteerism Award Memphis Business Journal Health Care Hero Award for Medical Innovation
Executive Director, West Cancer Center Chief, Division of Hematology/Oncology, the University of Tennessee Health Science Center Professor of Medicine, Division of Hematology/Oncology, the University of Tennessee Health Science Center Medical Director, West Clinic President/CMO, Vector Oncology Board of Directors, National Comprehensive Care Network
Areas of Expertise Breast Cancer Supportive Care Precision Oncology Research Dr. Schwartzberg’s current research projects include: New approaches to HER2+ breast cancer Neoadjuvant therapy with Androgen receptor modulators in breast cancer Molecular profiling of triple negative breast cancer New approaches to chemotherapy induced nausea and vomiting
Dr. Schwartzberg has published more than 150 peer reviewed articles in elite journals, including the Journal of Clinical Oncology, Lancet Oncology, and Annals of Oncology. To view Dr. Schwartzberg’s recent publications, click here.For Dr. Schwartzberg, fighting cancer is a calling, and the West Cancer Center is a dream come true.  
He is a Professor of Medicine and Chief of the Division of Hematology/Oncology at the University of Tennessee Health Science Center. He also serves as President/CMO for Vector Oncology, an oncology specific SMO/CRO. Dr. Schwartzberg was the founding editor-in-chief of the journal Community Oncology and currently serves as the editor-in-chief of the Practice Update Oncology website. He serves on the editorial board of both the Journal of Supportive Oncology and The ASCO Post, in addition to serving as a reviewer for many prominent medical journals, including the New England Journal of Medicine and the Journal of Clinical Oncology. Dr. Schwartzberg is also a member of the board of directors for the National Comprehensive Cancer Network.